These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 22554417)
1. Risk factors for age at initial Pseudomonas acquisition in the cystic fibrosis epic observational cohort. Rosenfeld M; Emerson J; McNamara S; Thompson V; Ramsey BW; Morgan W; Gibson RL; J Cyst Fibros; 2012 Sep; 11(5):446-53. PubMed ID: 22554417 [TBL] [Abstract][Full Text] [Related]
2. Baseline characteristics and factors associated with nutritional and pulmonary status at enrollment in the cystic fibrosis EPIC observational cohort. Rosenfeld M; Emerson J; McNamara S; Joubran K; Retsch-Bogart G; Graff GR; Gutierrez HH; Kanga JF; Lahiri T; Noyes B; Ramsey B; Ren CL; Schechter M; Morgan W; Gibson RL; Pediatr Pulmonol; 2010 Sep; 45(9):934-44. PubMed ID: 20597081 [TBL] [Abstract][Full Text] [Related]
3. Association of meteorological and geographical factors and risk of initial Pseudomonas aeruginosa acquisition in young children with cystic fibrosis. Psoter KJ; DE Roos AJ; Wakefield J; Mayer JD; Bryan M; Rosenfeld M Epidemiol Infect; 2016 Apr; 144(5):1075-83. PubMed ID: 26449886 [TBL] [Abstract][Full Text] [Related]
4. Mutations that permit residual CFTR function delay acquisition of multiple respiratory pathogens in CF patients. Green DM; McDougal KE; Blackman SM; Sosnay PR; Henderson LB; Naughton KM; Collaco JM; Cutting GR Respir Res; 2010 Oct; 11(1):140. PubMed ID: 20932301 [TBL] [Abstract][Full Text] [Related]
5. Longitudinal development of initial, chronic and mucoid Pseudomonas aeruginosa infection in young children with cystic fibrosis. Heltshe SL; Khan U; Beckett V; Baines A; Emerson J; Sanders DB; Gibson RL; Morgan W; Rosenfeld M J Cyst Fibros; 2018 May; 17(3):341-347. PubMed ID: 29110966 [TBL] [Abstract][Full Text] [Related]
6. Cystic fibrosis transmembrane conductance regulator (CFTR)-mediated residual chloride secretion does not protect against early chronic Pseudomonas aeruginosa infection in F508del homozygous cystic fibrosis patients. Derichs N; Mekus F; Bronsveld I; Bijman J; Veeze HJ; von der Hardt H; Tummler B; Ballmann M Pediatr Res; 2004 Jan; 55(1):69-75. PubMed ID: 14605249 [TBL] [Abstract][Full Text] [Related]
7. Clinical outcomes in infants with cystic fibrosis transmembrane conductance regulator (CFTR) related metabolic syndrome. Ren CL; Desai H; Platt M; Dixon M Pediatr Pulmonol; 2011 Nov; 46(11):1079-84. PubMed ID: 21538969 [TBL] [Abstract][Full Text] [Related]
8. Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition. Kosorok MR; Zeng L; West SE; Rock MJ; Splaingard ML; Laxova A; Green CG; Collins J; Farrell PM Pediatr Pulmonol; 2001 Oct; 32(4):277-87. PubMed ID: 11568988 [TBL] [Abstract][Full Text] [Related]
9. Genetic determinants of airways' colonisation with Pseudomonas aeruginosa in cystic fibrosis. Kubesch P; Dörk T; Wulbrand U; Kälin N; Neumann T; Wulf B; Geerlings H; Weissbrodt H; von der Hardt H; Tümmler B Lancet; 1993 Jan; 341(8839):189-93. PubMed ID: 7678316 [TBL] [Abstract][Full Text] [Related]
10. DCTN4 as a modifier of chronic Pseudomonas aeruginosa infection in cystic fibrosis. Viel M; Hubert D; Burgel PR; Génin E; Honoré I; Martinez B; Gaitch N; Chapron J; Kanaan R; Dusser D; Girodon E; Bienvenu T Clin Respir J; 2016 Nov; 10(6):777-783. PubMed ID: 25763772 [TBL] [Abstract][Full Text] [Related]
11. Clinical outcomes after initial pseudomonas acquisition in cystic fibrosis. Zemanick ET; Emerson J; Thompson V; McNamara S; Morgan W; Gibson RL; Rosenfeld M; Pediatr Pulmonol; 2015 Jan; 50(1):42-8. PubMed ID: 24644274 [TBL] [Abstract][Full Text] [Related]
12. Early Respiratory Bacterial Detection and Antistaphylococcal Antibiotic Prophylaxis in Young Children with Cystic Fibrosis. Hurley MN; Fogarty A; McKeever TM; Goss CH; Rosenfeld M; Smyth AR Ann Am Thorac Soc; 2018 Jan; 15(1):42-48. PubMed ID: 29035090 [TBL] [Abstract][Full Text] [Related]
13. Predictors of mucoid Pseudomonas colonization in cystic fibrosis patients. Levy H; Kalish LA; Cannon CL; García KC; Gerard C; Goldmann D; Pier GB; Weiss ST; Colin AA Pediatr Pulmonol; 2008 May; 43(5):463-71. PubMed ID: 18361452 [TBL] [Abstract][Full Text] [Related]
14. Air pollution exposure is associated with MRSA acquisition in young U.S. children with cystic fibrosis. Psoter KJ; De Roos AJ; Wakefield J; Mayer JD; Rosenfeld M BMC Pulm Med; 2017 Jul; 17(1):106. PubMed ID: 28750627 [TBL] [Abstract][Full Text] [Related]
15. Seasonality of acquisition of respiratory bacterial pathogens in young children with cystic fibrosis. Psoter KJ; De Roos AJ; Wakefield J; Mayer JD; Rosenfeld M BMC Infect Dis; 2017 Jun; 17(1):411. PubMed ID: 28599639 [TBL] [Abstract][Full Text] [Related]
17. Season is associated with Pseudomonas aeruginosa acquisition in young children with cystic fibrosis. Psoter KJ; De Roos AJ; Wakefield J; Mayer J; Rosenfeld M Clin Microbiol Infect; 2013 Nov; 19(11):E483-9. PubMed ID: 23795938 [TBL] [Abstract][Full Text] [Related]
18. Impact of Sustained Eradication of New Pseudomonas aeruginosa Infection on Long-term Outcomes in Cystic Fibrosis. Mayer-Hamblett N; Kloster M; Rosenfeld M; Gibson RL; Retsch-Bogart GZ; Emerson J; Thompson V; Ramsey BW Clin Infect Dis; 2015 Sep; 61(5):707-15. PubMed ID: 25972024 [TBL] [Abstract][Full Text] [Related]
19. Long-term effects of birth order and age at diagnosis in cystic fibrosis: a sibling cohort study. Slieker MG; van den Berg JM; Kouwenberg J; van Berkhout FT; Heijerman HG; van der Ent CK Pediatr Pulmonol; 2010 Jun; 45(6):601-7. PubMed ID: 20503286 [TBL] [Abstract][Full Text] [Related]
20. Respiratory pathogens mediate the association between lung function and temperature in cystic fibrosis. Collaco JM; Raraigh KS; Appel LJ; Cutting GR J Cyst Fibros; 2016 Nov; 15(6):794-801. PubMed ID: 27296562 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]